Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Symbiance is a technology-enabled contract research organization serving pharmaceutical, biotechnology, and medical device companies. The company focuses on outsourced clinical development support rather than proprietary drug development, with core offerings in clinical data management, clinical data standardization, biostatistics, SAS programming, pharmacovigilance, medical writing, and related clinical operations services. Symbiance presents itself as combining domain expertise with a “people + product” model and the use of machine learning, analytics, and AI-enabled tools to improve efficiency and decision-making in clinical research. Founded in 1990 and headquartered in Princeton, New Jersey, the company built a long-standing presence in clinical data services. In September 2025, Symbiance was acquired by ACL Digital to expand ACL Digital’s life sciences and clinical research capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Symbiance.